Company Overview

Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.

Latest Financial Results

Q3 2022

Quarter Ended Sep 30, 2022

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

Company Overview

Avenue Therapeutics is a specialty pharmaceutical company whose mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc.

Stock Information

IR Contacts

Headquarters

Avenue Therapeutics, Inc.
2 Gansevoort Street
9th Floor
New York, NY 10014

Investor Relations

Jaclyn Jaffe and Bill Begien
T: 781-652-4500
ir@avenuetx.com

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
info@vstocktransfer.com
https://www.vstocktransfer.com